<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-07-05" modified="2020-10-07" version="169">
<accession>Q92560</accession>
<accession>A8K993</accession>
<accession>Q6LEM0</accession>
<accession>Q7Z5E8</accession>
<name>BAP1_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="24">Ubiquitin carboxyl-terminal hydrolase BAP1</fullName>
<ecNumber evidence="11 20">3.4.19.12</ecNumber>
</recommendedName>
<alternativeName>
<fullName evidence="22">BRCA1-associated protein 1</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="23">Cerebral protein 6</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="22 25">BAP1</name>
<name type="synonym" evidence="21">KIAA0272</name>
<name type="ORF" evidence="23">hucep-6</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="Oncogene" volume="16" first="1097" last="1112">
<title>BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.</title>
<authorList>
<person name="Jensen D.E."/>
<person name="Proctor M."/>
<person name="Marquis S.T."/>
<person name="Gardner H.P."/>
<person name="Ha S.I."/>
<person name="Chodosh L.A."/>
<person name="Ishov A.M."/>
<person name="Tommerup N."/>
<person name="Vissing H."/>
<person name="Sekido Y."/>
<person name="Minna J."/>
<person name="Borodovsky A."/>
<person name="Schultz D.C."/>
<person name="Wilkinson K.D."/>
<person name="Maul G.G."/>
<person name="Barlev N."/>
<person name="Berger S."/>
<person name="Prendergast G.C."/>
<person name="Rauscher F.J. III"/>
</authorList>
<dbReference type="PubMed" id="9528852"/>
<dbReference type="DOI" id="10.1038/sj.onc.1201861"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>ENZYME ACTIVITY</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF CYS-91 AND LEU-691</scope>
<scope>INTERACTION WITH BRCA1</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<source>
<tissue>B-cell</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="1996-11" db="EMBL/GenBank/DDBJ databases">
<title>Biological functions of a novel human gene, hucep-6, which is specifically expressed in the central nervous system.</title>
<authorList>
<person name="Yoshimoto M."/>
<person name="Yazaki M."/>
<person name="Takayama K."/>
<person name="Matsumoto K."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1996" name="DNA Res." volume="3" first="321" last="329">
<title>Prediction of the coding sequences of unidentified human genes. VI. The coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by analysis of cDNA clones from cell line KG-1 and brain.</title>
<authorList>
<person name="Nagase T."/>
<person name="Seki N."/>
<person name="Ishikawa K."/>
<person name="Ohira M."/>
<person name="Kawarabayasi Y."/>
<person name="Ohara O."/>
<person name="Tanaka A."/>
<person name="Kotani H."/>
<person name="Miyajima N."/>
<person name="Nomura N."/>
</authorList>
<dbReference type="PubMed" id="9039502"/>
<dbReference type="DOI" id="10.1093/dnares/3.5.321"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2002" name="DNA Res." volume="9" first="99" last="106">
<title>Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.</title>
<authorList>
<person name="Nakajima D."/>
<person name="Okazaki N."/>
<person name="Yamakawa H."/>
<person name="Kikuno R."/>
<person name="Ohara O."/>
<person name="Nagase T."/>
</authorList>
<dbReference type="PubMed" id="12168954"/>
<dbReference type="DOI" id="10.1093/dnares/9.3.99"/>
</citation>
<scope>SEQUENCE REVISION</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="Int. J. Cancer" volume="106" first="244" last="251">
<title>Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries.</title>
<authorList>
<person name="Behrends U."/>
<person name="Schneider I."/>
<person name="Roessler S."/>
<person name="Frauenknecht H."/>
<person name="Golbeck A."/>
<person name="Lechner B."/>
<person name="Eigenstetter G."/>
<person name="Zobywalski C."/>
<person name="Mueller-Weihrich S."/>
<person name="Graubner U."/>
<person name="Schmid I."/>
<person name="Sackerer D."/>
<person name="Spaeth M."/>
<person name="Goetz C."/>
<person name="Prantl F."/>
<person name="Asmuss H.-P."/>
<person name="Bise K."/>
<person name="Mautner J."/>
</authorList>
<dbReference type="PubMed" id="12800201"/>
<dbReference type="DOI" id="10.1002/ijc.11208"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 164-729</scope>
<source>
<tissue>Medulloblastoma</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2011" name="Nat. Genet." volume="43" first="668" last="672">
<title>The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma.</title>
<authorList>
<person name="Bott M."/>
<person name="Brevet M."/>
<person name="Taylor B.S."/>
<person name="Shimizu S."/>
<person name="Ito T."/>
<person name="Wang L."/>
<person name="Creaney J."/>
<person name="Lake R.A."/>
<person name="Zakowski M.F."/>
<person name="Reva B."/>
<person name="Sander C."/>
<person name="Delsite R."/>
<person name="Powell S."/>
<person name="Zhou Q."/>
<person name="Shen R."/>
<person name="Olshen A."/>
<person name="Rusch V."/>
<person name="Ladanyi M."/>
</authorList>
<dbReference type="PubMed" id="21642991"/>
<dbReference type="DOI" id="10.1038/ng.855"/>
</citation>
<scope>INVOLVEMENT IN MESOM</scope>
<scope>VARIANTS CYS-63; VAL-81; TRP-91; ASP-95; ALA-315 AND VAL-685</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2011" name="Nat. Genet." volume="43" first="1018" last="1021">
<title>Germline mutations in BAP1 predispose to melanocytic tumors.</title>
<authorList>
<person name="Wiesner T."/>
<person name="Obenauf A.C."/>
<person name="Murali R."/>
<person name="Fried I."/>
<person name="Griewank K.G."/>
<person name="Ulz P."/>
<person name="Windpassinger C."/>
<person name="Wackernagel W."/>
<person name="Loy S."/>
<person name="Wolf I."/>
<person name="Viale A."/>
<person name="Lash A.E."/>
<person name="Pirun M."/>
<person name="Socci N.D."/>
<person name="Rutten A."/>
<person name="Palmedo G."/>
<person name="Abramson D."/>
<person name="Offit K."/>
<person name="Ott A."/>
<person name="Becker J.C."/>
<person name="Cerroni L."/>
<person name="Kutzner H."/>
<person name="Bastian B.C."/>
<person name="Speicher M.R."/>
</authorList>
<dbReference type="PubMed" id="21874003"/>
<dbReference type="DOI" id="10.1038/ng.910"/>
</citation>
<scope>INVOLVEMENT IN TPDS</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2011" name="Nat. Genet." volume="43" first="1022" last="1025">
<title>Germline BAP1 mutations predispose to malignant mesothelioma.</title>
<authorList>
<person name="Testa J.R."/>
<person name="Cheung M."/>
<person name="Pei J."/>
<person name="Below J.E."/>
<person name="Tan Y."/>
<person name="Sementino E."/>
<person name="Cox N.J."/>
<person name="Dogan A.U."/>
<person name="Pass H.I."/>
<person name="Trusa S."/>
<person name="Hesdorffer M."/>
<person name="Nasu M."/>
<person name="Powers A."/>
<person name="Rivera Z."/>
<person name="Comertpay S."/>
<person name="Tanji M."/>
<person name="Gaudino G."/>
<person name="Yang H."/>
<person name="Carbone M."/>
</authorList>
<dbReference type="PubMed" id="21874000"/>
<dbReference type="DOI" id="10.1038/ng.912"/>
</citation>
<scope>INVOLVEMENT IN TPDS AND MESOM</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-292; SER-369; SER-521; SER-537; SER-585 AND SER-597</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="1999" name="Cancer Lett." volume="143" first="S13" last="S17">
<title>Defining biochemical functions for the BRCA1 tumor suppressor protein: analysis of the BRCA1 binding protein BAP1.</title>
<authorList>
<person name="Jensen D.E."/>
<person name="Rauscher F.J. III"/>
</authorList>
<dbReference type="PubMed" id="10546591"/>
<dbReference type="DOI" id="10.1016/s0304-3835(99)90004-6"/>
</citation>
<scope>VARIANTS ASP-95 AND VAL-178</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2002" name="EMBO J." volume="21" first="6755" last="6762">
<title>Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains.</title>
<authorList>
<person name="Mallery D.L."/>
<person name="Vandenberg C.J."/>
<person name="Hiom K."/>
</authorList>
<dbReference type="PubMed" id="12485996"/>
<dbReference type="DOI" id="10.1093/emboj/cdf691"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="Cancer Res." volume="68" first="6953" last="6962">
<title>BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization.</title>
<authorList>
<person name="Ventii K.H."/>
<person name="Devi N.S."/>
<person name="Friedrich K.L."/>
<person name="Chernova T.A."/>
<person name="Tighiouart M."/>
<person name="Van Meir E.G."/>
<person name="Wilkinson K.D."/>
</authorList>
<dbReference type="PubMed" id="18757409"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-08-0365"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>NUCLEAR LOCALIZATION SIGNAL</scope>
<scope>MUTAGENESIS OF CYS-91; 656-LYS--ARG-661 AND 717-ARG--ARG-722</scope>
<scope>CHARACTERIZATION OF VARIANTS ASP-95 AND VAL-178</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2009" name="Cancer Res." volume="69" first="111" last="119">
<title>BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity.</title>
<authorList>
<person name="Nishikawa H."/>
<person name="Wu W."/>
<person name="Koike A."/>
<person name="Kojima R."/>
<person name="Gomi H."/>
<person name="Fukuda M."/>
<person name="Ohta T."/>
</authorList>
<dbReference type="PubMed" id="19117993"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-08-3355"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH BARD1 AND BRCA1</scope>
<scope>MUTAGENESIS OF CYS-91</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="34179" last="34188">
<title>The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1.</title>
<authorList>
<person name="Machida Y.J."/>
<person name="Machida Y."/>
<person name="Vashisht A.A."/>
<person name="Wohlschlegel J.A."/>
<person name="Dutta A."/>
</authorList>
<dbReference type="PubMed" id="19815555"/>
<dbReference type="DOI" id="10.1074/jbc.m109.046755"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH HCFC1</scope>
<scope>MUTAGENESIS OF CYS-91 AND 363-ASN--TYR-366</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Mol. Cell. Biol." volume="29" first="2181" last="2192">
<title>Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1.</title>
<authorList>
<person name="Misaghi S."/>
<person name="Ottosen S."/>
<person name="Izrael-Tomasevic A."/>
<person name="Arnott D."/>
<person name="Lamkanfi M."/>
<person name="Lee J."/>
<person name="Liu J."/>
<person name="O'Rourke K."/>
<person name="Dixit V.M."/>
<person name="Wilson A.C."/>
</authorList>
<dbReference type="PubMed" id="19188440"/>
<dbReference type="DOI" id="10.1128/mcb.01517-08"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH HCFC1</scope>
<scope>MUTAGENESIS OF CYS-91 AND 363-ASN--TYR-366</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2010" name="Nature" volume="465" first="243" last="247">
<title>Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB.</title>
<authorList>
<person name="Scheuermann J.C."/>
<person name="de Ayala Alonso A.G."/>
<person name="Oktaba K."/>
<person name="Ly-Hartig N."/>
<person name="McGinty R.K."/>
<person name="Fraterman S."/>
<person name="Wilm M."/>
<person name="Muir T.W."/>
<person name="Muller J."/>
</authorList>
<dbReference type="PubMed" id="20436459"/>
<dbReference type="DOI" id="10.1038/nature08966"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>IDENTIFICATION IN THE PR-DUB COMPLEX</scope>
<scope>INTERACTION WITH ASXL1</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2014" name="Mol. Cell" volume="54" first="392" last="406">
<title>Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O.</title>
<authorList>
<person name="Mashtalir N."/>
<person name="Daou S."/>
<person name="Barbour H."/>
<person name="Sen N.N."/>
<person name="Gagnon J."/>
<person name="Hammond-Martel I."/>
<person name="Dar H.H."/>
<person name="Therrien M."/>
<person name="Affar E.B."/>
</authorList>
<dbReference type="PubMed" id="24703950"/>
<dbReference type="DOI" id="10.1016/j.molcel.2014.03.002"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>UBIQUITINATION</scope>
<scope>NUCLEAR LOCALIZATION SIGNAL</scope>
<scope>MUTAGENESIS OF 691-LEU--LYS-711</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2014" name="Nucleic Acids Res." volume="42" first="6232" last="6242">
<title>The forkhead transcription factor FOXK2 acts as a chromatin targeting factor for the BAP1-containing histone deubiquitinase complex.</title>
<authorList>
<person name="Ji Z."/>
<person name="Mohammed H."/>
<person name="Webber A."/>
<person name="Ridsdale J."/>
<person name="Han N."/>
<person name="Carroll J.S."/>
<person name="Sharrocks A.D."/>
</authorList>
<dbReference type="PubMed" id="24748658"/>
<dbReference type="DOI" id="10.1093/nar/gku274"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH FOXK2</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2015" name="J. Biol. Chem." volume="290" first="1580" last="1591">
<title>BRCA1-associated protein 1 (BAP1) deubiquitinase antagonizes the ubiquitin-mediated activation of FoxK2 target genes.</title>
<authorList>
<person name="Okino Y."/>
<person name="Machida Y."/>
<person name="Frankland-Searby S."/>
<person name="Machida Y.J."/>
</authorList>
<dbReference type="PubMed" id="25451922"/>
<dbReference type="DOI" id="10.1074/jbc.m114.609834"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH FOXK1 AND FOXK2</scope>
<scope>PHOSPHORYLATION AT THR-493</scope>
<scope>MUTAGENESIS OF CYS-91; SER-489; SER-492; THR-493 AND THR-495</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2015" name="Clin. Genet." volume="88" first="273" last="277">
<title>Germline BAP1 mutations predispose also to multiple basal cell carcinomas.</title>
<authorList>
<person name="de la Fouchardiere A."/>
<person name="Cabaret O."/>
<person name="Savin L."/>
<person name="Combemale P."/>
<person name="Schvartz H."/>
<person name="Penet C."/>
<person name="Bonadona V."/>
<person name="Soufir N."/>
<person name="Bressac-de Paillerets B."/>
</authorList>
<dbReference type="PubMed" id="25080371"/>
<dbReference type="DOI" id="10.1111/cge.12472"/>
</citation>
<scope>VARIANT PHE-47</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2015" name="Sci. Rep." volume="5" first="18462" last="18462">
<title>Cancer associated missense mutations in BAP1 catalytic domain induce amyloidogenic aggregation: A new insight in enzymatic inactivation.</title>
<authorList>
<person name="Bhattacharya S."/>
<person name="Hanpude P."/>
<person name="Maiti T.K."/>
</authorList>
<dbReference type="PubMed" id="26680512"/>
<dbReference type="DOI" id="10.1038/srep18462"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS PHE-47; VAL-81; ASP-95 AND VAL-178</scope>
</reference>
<comment type="function">
<text evidence="6 7 8 9 10 11 15 18 20">Deubiquitinating enzyme that plays a key role in chromatin by mediating deubiquitination of histone H2A and HCFC1 (PubMed:12485996, PubMed:18757409, PubMed:20436459, PubMed:25451922). Catalytic component of the PR-DUB complex, a complex that specifically mediates deubiquitination of histone H2A monoubiquitinated at 'Lys-119' (H2AK119ub1) (PubMed:20436459, PubMed:25451922). Does not deubiquitinate monoubiquitinated histone H2B (PubMed:20436459). Acts as a regulator of cell growth by mediating deubiquitination of HCFC1 N-terminal and C-terminal chains, with some specificity toward 'Lys-48'-linked polyubiquitin chains compared to 'Lys-63'-linked polyubiquitin chains (PubMed:19188440, PubMed:19815555). Deubiquitination of HCFC1 does not lead to increase stability of HCFC1 (PubMed:19188440, PubMed:19815555). Interferes with the BRCA1 and BARD1 heterodimer activity by inhibiting their ability to mediate ubiquitination and autoubiquitination (PubMed:19117993). It however does not mediate deubiquitination of BRCA1 and BARD1 (PubMed:19117993). Able to mediate autodeubiquitination via intramolecular interactions to couteract monoubiquitination at the nuclear localization signal (NLS), thereby protecting it from cytoplasmic sequestration (PubMed:24703950). Acts as a tumor suppressor (PubMed:9528852).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="11 20">
<text>Thiol-dependent hydrolysis of ester, thioester, amide, peptide and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-residue protein attached to proteins as an intracellular targeting signal).</text>
<dbReference type="EC" id="3.4.19.12"/>
</reaction>
</comment>
<comment type="subunit">
<text evidence="8 9 10 11 16 18 20">Component of the PR-DUB complex, at least composed of BAP1 and ASXL1 (PubMed:20436459). Interacts with BRCA1 (via the RING finger) (PubMed:19117993, PubMed:9528852). Interacts (via HBM-like motif) with HCFC1 (PubMed:19188440, PubMed:19815555). Interacts (when phosphorylated at Thr-493) with FOXK1 (PubMed:25451922). Interacts (when phosphorylated at Thr-493) with FOXK2; leading to recruit the PR-DUB complex and repress FOXK2 target genes (PubMed:24748658, PubMed:25451922).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1791447">
<id>Q92560</id>
</interactant>
<interactant intactId="EBI-1646500">
<id>Q8IXJ9</id>
<label>ASXL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1791447">
<id>Q92560</id>
</interactant>
<interactant intactId="EBI-349905">
<id>P38398</id>
<label>BRCA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1791447">
<id>Q92560</id>
</interactant>
<interactant intactId="EBI-2015072">
<id>P38398-5</id>
<label>BRCA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1791447">
<id>Q92560</id>
</interactant>
<interactant intactId="EBI-396176">
<id>P51610</id>
<label>HCFC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1791447">
<id>Q92560</id>
</interactant>
<interactant intactId="EBI-351055">
<id>Q14573</id>
<label>ITPR3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="7 9 10 15">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="7 9 10 15 16 20">Nucleus</location>
</subcellularLocation>
<text evidence="15">Mainly nuclear. Binds to chromatin. Localizes to the cytoplasm when monoubiquitinated by the E2/E3 hybrid ubiquitin-protein ligase UBE2O (PubMed:24703950).</text>
</comment>
<comment type="tissue specificity">
<text evidence="20">Highly expressed in testis, placenta and ovary. Expressed in breast.</text>
</comment>
<comment type="PTM">
<text evidence="15">Ubiquitinated: monoubiquitinated at multiple site of its nuclear localization signal (NLS) BY UBE2O, leading to cytoplasmic retention. Able to mediate autodeubiquitination via intramolecular interactions to couteract cytoplasmic retention.</text>
</comment>
<comment type="disease" evidence="12 13">
<disease id="DI-03213">
<name>Mesothelioma, malignant</name>
<acronym>MESOM</acronym>
<description>An aggressive neoplasm of the serosal lining of the chest. It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos.</description>
<dbReference type="MIM" id="156240"/>
</disease>
<text>The gene represented in this entry is involved in disease pathogenesis.</text>
</comment>
<comment type="disease" evidence="13 14">
<disease id="DI-03304">
<name>Tumor predisposition syndrome</name>
<acronym>TPDS</acronym>
<description>A condition characterized by predisposition to develop a variety of tumors, including benign melanocytic tumors as well as several malignant tumors, including uveal melanoma, cutaneous melanoma, malignant mesothelioma on exposure to asbestos, lung adenocarcinoma and meningioma.</description>
<dbReference type="MIM" id="614327"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="24">Belongs to the peptidase C12 family. BAP1 subfamily.</text>
</comment>
<comment type="caution">
<text evidence="16 18">According to a report, interaction with FOXK2 is not dependent on phosphorylation of BAP1 (PubMed:24748658). However, it was later shown that phosphorylation at Thr-493 promotes interaction with FOXK2 (PubMed:25451922).</text>
</comment>
<comment type="sequence caution" evidence="24">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAA13401" version="2"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/BAP1ID755ch3p21.html"/>
</comment>
<dbReference type="EC" id="3.4.19.12" evidence="11 20"/>
<dbReference type="EMBL" id="AF045581">
<property type="protein sequence ID" value="AAC15970.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D88812">
<property type="protein sequence ID" value="BAB46921.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="D87462">
<property type="protein sequence ID" value="BAA13401.2"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK292608">
<property type="protein sequence ID" value="BAF85297.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471055">
<property type="protein sequence ID" value="EAW65220.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC001596">
<property type="protein sequence ID" value="AAH01596.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY130008">
<property type="protein sequence ID" value="AAN05092.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2853.1"/>
<dbReference type="RefSeq" id="NP_004647.1">
<property type="nucleotide sequence ID" value="NM_004656.3"/>
</dbReference>
<dbReference type="SMR" id="Q92560"/>
<dbReference type="BioGRID" id="113911">
<property type="interactions" value="103"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-414">
<property type="entry name" value="PR-DUB complex"/>
</dbReference>
<dbReference type="DIP" id="DIP-47004N"/>
<dbReference type="IntAct" id="Q92560">
<property type="interactions" value="59"/>
</dbReference>
<dbReference type="MINT" id="Q92560"/>
<dbReference type="STRING" id="9606.ENSP00000417132"/>
<dbReference type="BindingDB" id="Q92560"/>
<dbReference type="ChEMBL" id="CHEMBL1293314"/>
<dbReference type="MEROPS" id="C12.004"/>
<dbReference type="iPTMnet" id="Q92560"/>
<dbReference type="MetOSite" id="Q92560"/>
<dbReference type="PhosphoSitePlus" id="Q92560"/>
<dbReference type="BioMuta" id="BAP1"/>
<dbReference type="DMDM" id="68565074"/>
<dbReference type="EPD" id="Q92560"/>
<dbReference type="jPOST" id="Q92560"/>
<dbReference type="MassIVE" id="Q92560"/>
<dbReference type="MaxQB" id="Q92560"/>
<dbReference type="PaxDb" id="Q92560"/>
<dbReference type="PeptideAtlas" id="Q92560"/>
<dbReference type="PRIDE" id="Q92560"/>
<dbReference type="ProteomicsDB" id="75316"/>
<dbReference type="Antibodypedia" id="3812">
<property type="antibodies" value="427 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000460680">
<property type="protein sequence ID" value="ENSP00000417132"/>
<property type="gene ID" value="ENSG00000163930"/>
</dbReference>
<dbReference type="GeneID" id="8314"/>
<dbReference type="KEGG" id="hsa:8314"/>
<dbReference type="UCSC" id="uc003ddx.5">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="8314"/>
<dbReference type="DisGeNET" id="8314"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000163930.9"/>
<dbReference type="GeneCards" id="BAP1"/>
<dbReference type="GeneReviews" id="BAP1"/>
<dbReference type="HGNC" id="HGNC:950">
<property type="gene designation" value="BAP1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000163930">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="BAP1"/>
<dbReference type="MIM" id="156240">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="603089">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="614327">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q92560"/>
<dbReference type="OpenTargets" id="ENSG00000163930"/>
<dbReference type="Orphanet" id="289539">
<property type="disease" value="BAP1-related tumor predisposition syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="618">
<property type="disease" value="Familial melanoma"/>
</dbReference>
<dbReference type="Orphanet" id="39044">
<property type="disease" value="Uveal melanoma"/>
</dbReference>
<dbReference type="PharmGKB" id="PA25254"/>
<dbReference type="eggNOG" id="KOG2778">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000156388"/>
<dbReference type="HOGENOM" id="CLU_018316_5_0_1"/>
<dbReference type="InParanoid" id="Q92560"/>
<dbReference type="KO" id="K08588"/>
<dbReference type="OMA" id="HDKKQQD"/>
<dbReference type="OrthoDB" id="1363547at2759"/>
<dbReference type="PhylomeDB" id="Q92560"/>
<dbReference type="TreeFam" id="TF313976"/>
<dbReference type="BRENDA" id="3.4.19.12">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="PathwayCommons" id="Q92560"/>
<dbReference type="Reactome" id="R-HSA-5689603">
<property type="pathway name" value="UCH proteinases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5693565">
<property type="pathway name" value="Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks"/>
</dbReference>
<dbReference type="SIGNOR" id="Q92560"/>
<dbReference type="BioGRID-ORCS" id="8314">
<property type="hits" value="419 hits in 880 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="BAP1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="BAP1"/>
<dbReference type="GenomeRNAi" id="8314"/>
<dbReference type="Pharos" id="Q92560">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q92560"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="RNAct" id="Q92560">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000163930">
<property type="expression patterns" value="Expressed in testis and 207 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q92560">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q92560">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035517">
<property type="term" value="C:PR-DUB complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008233">
<property type="term" value="F:peptidase activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004843">
<property type="term" value="F:thiol-dependent ubiquitin-specific protease activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036459">
<property type="term" value="F:thiol-dependent ubiquitinyl hydrolase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006464">
<property type="term" value="P:cellular protein modification process"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061519">
<property type="term" value="P:macrophage homeostasis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035522">
<property type="term" value="P:monoubiquitinated histone H2A deubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035520">
<property type="term" value="P:monoubiquitinated protein deubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903955">
<property type="term" value="P:positive regulation of protein targeting to mitochondrion"/>
<property type="evidence" value="ECO:0007001"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071108">
<property type="term" value="P:protein K48-linked deubiquitination"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051726">
<property type="term" value="P:regulation of cell cycle"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001558">
<property type="term" value="P:regulation of cell growth"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900015">
<property type="term" value="P:regulation of cytokine production involved in inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010035">
<property type="term" value="P:response to inorganic substance"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006511">
<property type="term" value="P:ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.532.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR038765">
<property type="entry name" value="Papain-like_cys_pep_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001578">
<property type="entry name" value="Peptidase_C12_UCH"/>
</dbReference>
<dbReference type="InterPro" id="IPR036959">
<property type="entry name" value="Peptidase_C12_UCH_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR041507">
<property type="entry name" value="UCH_C"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10589">
<property type="entry name" value="PTHR10589"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01088">
<property type="entry name" value="Peptidase_C12"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18031">
<property type="entry name" value="UCH_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00707">
<property type="entry name" value="UBCTHYDRLASE"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF54001">
<property type="entry name" value="SSF54001"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0156">Chromatin regulator</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0645">Protease</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0788">Thiol protease</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<feature type="chain" description="Ubiquitin carboxyl-terminal hydrolase BAP1" id="PRO_0000211069">
<location>
<begin position="1"/>
<end position="729"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with BRCA1">
<location>
<begin position="596"/>
<end position="721"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="4">
<location>
<begin position="630"/>
<end position="661"/>
</location>
</feature>
<feature type="short sequence motif" description="HBM-like motif" evidence="9 10 18">
<location>
<begin position="363"/>
<end position="366"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal" evidence="7 15">
<location>
<begin position="717"/>
<end position="722"/>
</location>
</feature>
<feature type="active site" description="Nucleophile" evidence="7 8 9 10 18 20">
<location>
<position position="91"/>
</location>
</feature>
<feature type="active site" description="Proton donor" evidence="2">
<location>
<position position="169"/>
</location>
</feature>
<feature type="site" description="Important for enzyme activity" evidence="2">
<location>
<position position="184"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="292"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="369"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="395"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="18">
<location>
<position position="493"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="521"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="537"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="585"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="597"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a primary uveal melanoma; somatic mutation; induces cytoplasmic accumulation; loss of deubiquitinase activity; upregulates heat shock response; induces formation of amyloid-beta aggregates." id="VAR_075251" evidence="17 19">
<original>I</original>
<variation>F</variation>
<location>
<position position="47"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a malignant pleural mesothelioma sample; somatic mutation; dbSNP:rs747311942." id="VAR_065976" evidence="12">
<original>S</original>
<variation>C</variation>
<location>
<position position="63"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a malignant pleural mesothelioma sample; somatic mutation; induces cytoplasmic accumulation; loss of deubiquitinase activity; upregulates heat shock response; induces formation of amyloid-beta aggregates." id="VAR_065977" evidence="12 19">
<original>F</original>
<variation>V</variation>
<location>
<position position="81"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a malignant pleural mesothelioma sample." id="VAR_065978" evidence="12">
<original>C</original>
<variation>W</variation>
<location>
<position position="91"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung cancer sample; also found in a malignant pleural mesothelioma cell line; induces cytoplasmic accumulation; loss of deubiquitinase activity; upregulates heat shock response; induces formation of amyloid-beta aggregates." id="VAR_063498" evidence="5 7 12 19">
<original>A</original>
<variation>D</variation>
<location>
<position position="95"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung cancer sample; induces cytoplasmic accumulation; impairs deubiquitinase activity; upregulates heat shock response; induces formation of beta-amyloid aggregates." id="VAR_063499" evidence="5 7 19">
<original>G</original>
<variation>V</variation>
<location>
<position position="178"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a malignant pleural mesothelioma sample; dbSNP:rs149974450." id="VAR_065979" evidence="12">
<original>E</original>
<variation>A</variation>
<location>
<position position="315"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35353781." id="VAR_051517">
<original>V</original>
<variation>E</variation>
<location>
<position position="616"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a malignant pleural mesothelioma cell line." id="VAR_065980" evidence="12">
<original>E</original>
<variation>V</variation>
<location>
<position position="685"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes enzymatic activity without affecting its ability to interfere with BRCA1 E3 ligase activity. Does not affect interaction with FOXK1 and FOXK2." evidence="7 8 9 10 18 20">
<original>C</original>
<variation>A</variation>
<variation>S</variation>
<location>
<position position="91"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with HCFC1 without affecting interaction with FOXK1 and FOXK2." evidence="9 10 18">
<original>NHNY</original>
<variation>AAAA</variation>
<location>
<begin position="363"/>
<end position="366"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect interaction with FOXK1 and FOXK2." evidence="18">
<original>S</original>
<variation>A</variation>
<location>
<position position="489"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect interaction with FOXK1 and FOXK2." evidence="18">
<original>S</original>
<variation>A</variation>
<location>
<position position="492"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolished interaction with FOXK1 and FOXK2." evidence="18">
<original>T</original>
<variation>A</variation>
<variation>L</variation>
<location>
<position position="493"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect interaction with FOXK1 and FOXK2." evidence="18">
<original>T</original>
<variation>A</variation>
<location>
<position position="495"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect nuclear localization." evidence="7">
<original>KRKKFK</original>
<variation>AAAAAA</variation>
<location>
<begin position="656"/>
<end position="661"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes ubiquitination by UBE2O." evidence="15">
<location>
<begin position="691"/>
<end position="711"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with BRCA1." evidence="20">
<original>L</original>
<variation>P</variation>
<location>
<position position="691"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes nuclear localization." evidence="7">
<original>RRKRSR</original>
<variation>AAAAAA</variation>
<location>
<begin position="717"/>
<end position="722"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P09936"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q99PU7"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10546591"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12485996"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18757409"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19117993"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19188440"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19815555"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20436459"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21642991"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21874000"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21874003"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24703950"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24748658"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25080371"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25451922"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26680512"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9528852"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9039502"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9528852"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000303">
<source ref="2"/>
</evidence>
<evidence key="24" type="ECO:0000305"/>
<evidence key="25" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:950"/>
</source>
</evidence>
<sequence length="729" mass="80362" checksum="031DA03AE1841D85" modified="1998-11-01" version="2">MNKGWLELESDPGLFTLLVEDFGVKGVQVEEIYDLQSKCQGPVYGFIFLFKWIEERRSRRKVSTLVDDTSVIDDDIVNNMFFAHQLIPNSCATHALLSVLLNCSSVDLGPTLSRMKDFTKGFSPESKGYAIGNAPELAKAHNSHARPEPRHLPEKQNGLSAVRTMEAFHFVSYVPITGRLFELDGLKVYPIDHGPWGEDEEWTDKARRVIMERIGLATAGEPYHDIRFNLMAVVPDRRIKYEARLHVLKVNRQTVLEALQQLIRVTQPELIQTHKSQESQLPEESKSASNKSPLVLEANRAPAASEGNHTDGAEEAAGSCAQAPSHSPPNKPKLVVKPPGSSLNGVHPNPTPIVQRLPAFLDNHNYAKSPMQEEEDLAAGVGRSRVPVRPPQQYSDDEDDYEDDEEDDVQNTNSALRYKGKGTGKPGALSGSADGQLSVLQPNTINVLAEKLKESQKDLSIPLSIKTSSGAGSPAVAVPTHSQPSPTPSNESTDTASEIGSAFNSPLRSPIRSANPTRPSSPVTSHISKVLFGEDDSLLRVDCIRYNRAVRDLGPVISTGLLHLAEDGVLSPLALTEGGKGSSPSIRPIQGSQGSSSPVEKEVVEATDSREKTGMVRPGEPLSGEKYSPKELLALLKCVEAEIANYEACLKEEVEKRKKFKIDDQRRTHNYDEFICTFISMLAQEGMLANLVEQNISVRRRQGVSIGRLHKQRKPDRRKRSRPYKAKRQ</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

